Citigroup’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.1M Buy
263,375
+90,813
+53% +$30.9M 0.06% 449
2025
Q4
$68.6M Buy
172,562
+111,696
+184% +$49.4M 0.05% 510
2025
Q3
$27.8M Sell
60,866
-187,372
-75% -$76.3M 0.02% 897
2025
Q2
$80.9M Buy
248,238
+53,504
+27% +$14.8M 0.06% 405
2025
Q1
$52.6M Buy
194,734
+107,837
+124% +$27.7M 0.04% 540
2024
Q4
$20.4M Buy
86,897
+12,626
+17% +$3.32M 0.02% 946
2024
Q3
$20.4M Sell
74,271
-327,389
-82% -$85.2M 0.02% 932
2024
Q2
$97.6M Buy
401,660
+250,970
+167% +$39.6M 0.09% 282
2024
Q1
$22.5M Buy
150,690
+77,889
+107% +$13M 0.02% 830
2023
Q4
$13.9M Sell
72,801
-6,698
-8% -$1.14M 0.02% 1040
2023
Q3
$14.1M Buy
79,499
+18,295
+30% +$3.49M 0.02% 943
2023
Q2
$11.6M Sell
61,204
-17,657
-22% -$3.5M 0.02% 1077
2023
Q1
$15.8M Sell
78,861
-117,400
-60% -$24.7M 0.02% 929
2022
Q4
$46.6M Buy
196,261
+12,231
+7% +$2.61M 0.07% 425
2022
Q3
$36.8M Buy
184,030
+44,038
+31% +$8.4M 0.05% 491
2022
Q2
$20.4M Buy
139,992
+82,983
+146% +$11.8M 0.03% 790
2022
Q1
$9.31M Sell
57,009
-12,301
-18% -$1.87M 0.01% 1337
2021
Q4
$11.8M Sell
69,310
-1,682
-2% -$313K 0.01% 1303
2021
Q3
$13.4M Sell
70,992
-12,160
-15% -$2.28M 0.01% 1235
2021
Q2
$14.1M Sell
83,152
-2,325
-3% -$341K 0.01% 1210
2021
Q1
$12.1M Buy
85,477
+19,962
+30% +$3M 0.01% 1258
2020
Q4
$8.52M Sell
65,515
-37,072
-36% -$4.95M 0.01% 1696
2020
Q3
$14.9M Buy
102,587
+48,994
+91% +$6.96M 0.02% 1086
2020
Q2
$7.94M Buy
53,593
+13,395
+33% +$1.81M 0.01% 1490
2020
Q1
$4.37M Sell
40,198
-16,710
-29% -$1.93M 0.01% 1791
2019
Q4
$6.55M Sell
56,908
-43,894
-44% -$4.38M 0.01% 1805
2019
Q3
$8.11M Buy
100,802
+70,078
+228% +$5.54M 0.01% 1551
2019
Q2
$2.23M Buy
30,724
+18,978
+162% +$1.46M ﹤0.01% 2739
2019
Q1
$1.1M Sell
11,746
-67,301
-85% -$5.63M ﹤0.01% 3293
2018
Q4
$5.76M Buy
79,047
+28,913
+58% +$2.22M 0.01% 1695
2018
Q3
$4.39M Buy
50,134
+11,947
+31% +$1.2M 0.01% 1982
2018
Q2
$3.76M Sell
38,187
-15,409
-29% -$1.53M 0.01% 2107
2018
Q1
$6.38M Sell
53,596
-31,500
-37% -$4.06M 0.01% 1567
2017
Q4
$10.8M Buy
85,096
+52,519
+161% +$6.6M 0.02% 1238
2017
Q3
$3.83M Sell
32,577
-17,156
-34% -$1.46M 0.01% 2018
2017
Q2
$3.97M Buy
49,733
+5,214
+12% +$333K 0.01% 1907
2017
Q1
$2.28M Sell
44,519
-86,520
-66% -$4M ﹤0.01% 2342
2016
Q4
$4.91M Buy
131,039
+36,612
+39% +$1.53M 0.01% 1863
2016
Q3
$6.4M Buy
94,427
+13,551
+17% +$956K 0.01% 1448
2016
Q2
$4.49M Buy
80,876
+6,647
+9% +$419K 0.01% 1662
2016
Q1
$4.66M Buy
74,229
+3,794
+5% +$252K 0.01% 1625
2015
Q4
$6.63M Sell
70,435
-24,842
-26% -$2.3M 0.01% 1458
2015
Q3
$7.66M Buy
95,277
+12,769
+15% +$1.42M 0.02% 1348
2015
Q2
$9.89M Buy
82,508
+3,756
+5% +$449K 0.02% 1208
2015
Q1
$8.22M Buy
78,752
+47,827
+155% +$4.85M 0.02% 1338
2014
Q4
$3M Sell
30,925
-54,686
-64% -$5.07M 0.01% 2182
2014
Q3
$6.69M Buy
85,611
+70,281
+458% +$4.53M 0.01% 1608
2014
Q2
$968K Sell
15,330
-5,573
-27% -$331K ﹤0.01% 2992
2014
Q1
$1.4M Sell
20,903
-4,625
-18% -$358K ﹤0.01% 2609
2013
Q4
$1.64M Buy
25,528
+5,841
+30% +$348K ﹤0.01% 2753
2013
Q3
$1.26M Buy
19,687
+10,009
+103% +$499K ﹤0.01% 2741
2013
Q2
$300K Buy
+9,678
New +$258K ﹤0.01% 3920

Other funds holding ALNY